T
Thomas N. Walsh
Researcher at Royal College of Surgeons in Ireland
Publications - 139
Citations - 5011
Thomas N. Walsh is an academic researcher from Royal College of Surgeons in Ireland. The author has contributed to research in topics: Chemoradiotherapy & Cancer. The author has an hindex of 31, co-authored 127 publications receiving 4735 citations. Previous affiliations of Thomas N. Walsh include Trinity College, Dublin & Mater Misericordiae Hospital.
Papers
More filters
Journal ArticleDOI
A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.
TL;DR: Multimodal treatment is superior to surgery alone for patients with resectable adenocarcinoma of the esophagus, with the survival advantage favoring multimodal therapy reaching significance at three years.
Journal ArticleDOI
Endoscopic transthoracic electrocautery of the sympathetic chain for palmar and axillary hyperhidrosis.
TL;DR: As a minimally invasive procedure, endoscopic transthoracic electrocautery should be considered the treatment of choice for palmar and axillary hyperhidrosis.
Journal ArticleDOI
Micrometastases in esophagogastric cancer: High detection rate in resected rib segments
Gerald C. O'Sullivan,Dyan Sheehan,Andrew Clarke,Robert Stuart,Jacqui Kelly,M.David Kiely,Thomas N. Walsh,J. Kevin Collins,Fergus Shanahan +8 more
TL;DR: Most patients undergoing resection of esophagogastric malignancies have micrometastases in rib marrow, and the metastatic cells are viable, tumorigenic, and resistant to neoadjuvant therapy.
Journal ArticleDOI
Chylothorax after oesophagectomy
TL;DR: There was a significant correlation between chylothorax and the type of operative procedure carried out, and Conservative management alone was successful in four out of eight patients, with closure of the fistula at a median of 35 days.
Journal ArticleDOI
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data
Ulrich Ronellenfitsch,Matthias Schwarzbach,Ralf Hofheinz,Peter Kienle,Meinhard Kieser,Tracy E. Slanger,Bryan Burmeister,David P. Kelsen,Donna Niedzwiecki,Christoph Schuhmacher,Susan G. Urba,Cornelis J.H. van de Velde,Thomas N. Walsh,Marc Ychou,Katrin Jensen +14 more
TL;DR: Preoperative chemotherapy for locoregional gastroesophageal adenocarcinoma increases survival compared to surgery alone and should be offered to all eligible patients.